Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Tsuboi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Leukemia Research|May 14, 2011
A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemiaKosuke Tsuboi, Toshiya Yokozawa, Toru Sakura, et al.
International Journal of Hematology|December 2, 2015
Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodiesMinoru Kojima, Akitada Ichinose, Masayoshi Souri, et al.
International Journal of Hematology|January 15, 2008
Prognostic significance of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia in an unselected patient populationRikio Suzuki, Makoto Onizuka, Minoru Kojima, et al.
Blood|August 7, 2004
Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarctionHiroshi Kawada, Jun Fujita, Kentaro Kinjo, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 25, 2014
Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's LymphomaHiroshi Kawada, Masakazu Sawanobori, Mitsuyo Tsuma-Kaneko, et al.
Blood|February 16, 2013
Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemiaMasamitsu Yanada, Motohiro Tsuzuki, Hiroyuki Fujita, et al.
International Journal of Hematology|September 11, 2010
Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 studyItsuro Jinnai, Tohru Sakura, Motohiro Tsuzuki, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Leukemia Research|May 14, 2011
A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemiaKosuke Tsuboi, Toshiya Yokozawa, Toru Sakura, et al.
International Journal of Hematology|December 2, 2015
Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodiesMinoru Kojima, Akitada Ichinose, Masayoshi Souri, et al.
International Journal of Hematology|January 15, 2008
Prognostic significance of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia in an unselected patient populationRikio Suzuki, Makoto Onizuka, Minoru Kojima, et al.
Blood|August 7, 2004
Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarctionHiroshi Kawada, Jun Fujita, Kentaro Kinjo, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 25, 2014
Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's LymphomaHiroshi Kawada, Masakazu Sawanobori, Mitsuyo Tsuma-Kaneko, et al.
Blood|February 16, 2013
Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemiaMasamitsu Yanada, Motohiro Tsuzuki, Hiroyuki Fujita, et al.
International Journal of Hematology|September 11, 2010
Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 studyItsuro Jinnai, Tohru Sakura, Motohiro Tsuzuki, et al.
Pageof 2